NEWARK, N.J., Dec. 5, 2019 /PRNewswire/ -- Rafael Holdings,
Inc., (NYSE: RFL), announced that it will present at the 12th
Annual LD Micro Main Event investor conference.
David Polinsky, Rafael's Chief
Financial Officer, and Ari Landon,
Director of Rafael Holdings' cancer therapy development initiative
- the Barer Institute, will discuss the company's unique portfolio
of assets including its majority stake in Rafael
Pharmaceuticals. Rafael Pharmaceuticals is currently
conducting two Phase III trials of its promising lead compound,
devimistat (CPI-613®), for patients with pancreatic cancer and
acute myeloid leukemia (AML) as well as additional trials in
multiple indications with high unmet needs.
The 12th Annual LD Micro Main Event will host more
than 250 innovative companies in technology, biotech,
pharmaceuticals, mining, energy and other sectors. The
conference will be held at the Luxe Sunset Bel Air Hotel in
Bel Air, CA on December
10th-12th.
Management will present at 4 PM on
the 10th and meet with attendees throughout the day on
December 10th and
11th. To register and attend the LD Micro Main
Event, contact David Scher at
david@ldmicro.com or visit https://www.ldmicro.com/ for more
information.
The Rafael Holdings presentation will be webcast here and
subsequently available for replay through the investor
presentations page of the Company's website.
About Rafael Holdings, Inc.:
Rafael Holdings holds
commercial real estate assets and interests in development and
clinical stage pharmaceutical companies. The real estate
holdings consist of properties in Newark and Piscataway, New Jersey and Jerusalem, Israel. The pharmaceutical
holdings include interests in two companies focused on the
development and commercialization of oncology drugs: Rafael
Pharmaceuticals, Inc. and LipoMedix Pharmaceuticals Ltd. Through
its Barer Institute initiative, Rafael Holdings is developing a
pipeline of therapeutic compounds including compounds to regulate
cancer metabolism. For more information, visit
https://rafaelholdings.com/
About LD Micro:
LD Micro was founded in 2006 with the
sole purpose of being an independent resource in the microcap
space. What started out as a newsletter highlighting unique
companies has transformed into several influential events annually
(Invitational, Summit, and Main Event). In 2015, LDM launched
the first pure microcap index (the LDMi) to exclusively provide
intraday information on the entire sector. LD will continue to
provide valuable tools for the benefit of everyone in the small and
micro-cap universe.
All statements above that are not purely about historical
facts, including, but not limited to, those in which we use the
words "believe," "anticipate," "expect," "plan," "intend,"
"estimate," "target" and similar expressions, are forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 1995. While these forward-looking statements
represent our current judgment of what may happen in the future,
actual results may differ materially from the results expressed or
implied by these statements due to numerous important factors. Our
filings with the SEC provide detailed information on such
statements and risks, and should be consulted along with this
release. To the extent permitted under applicable law, we assume no
obligation to update any forward-looking statements.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/rafael-holdings-to-present-at-ld-micro-main-event-300970391.html
SOURCE Rafael Holdings, Inc.